Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ).
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has announced the composition of its board of directors and the roles and functions of its members. The board comprises executive and independent non-executive directors, and it has established four committees to oversee various aspects of the company’s governance and strategic direction. This announcement reflects the company’s commitment to structured governance and strategic oversight, which may impact its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$25.40 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company based in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on the development, production, and distribution of pharmaceutical products.
Average Trading Volume: 1,388,448
Technical Sentiment Signal: Sell
Current Market Cap: HK$45.22B
Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue